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Variations in muscle cell protein of severely uremic children. Al-
kali-soluble protein (ASP) was determined in the muscle of 17
controls and 32 uremic children including 9 patients receiving
intermittent hemodialysis. With regard to fat-free solids content
(FFS), ASP values were found to be lower in uremic children than
in normal subjects (59.2 + 1.6 vs. 76.4 + 1.9 g/100 g of FFS). This
decrease was greater in hemodialyzed children (53.8 + 1.6 g/100 g
of FFS). ASP depletion was found also when the results were
expressed in relation to muscle potassium and phosphorus and
therefore appeared to be due to an actual decrease in the amount of
proteins per cell. ASP values were especially low (52.2 2.8 g/lOO
g of FFS) in seven nondialyzed children receiving a low protein
diet (<0.165 g of N/kg of body wt/day) and in patients with a
height below 2 SD (56.3 + 3.1 g/l00 g of FFS). In the nine cases of
glomerulonephritis, loss of muscle proteins followed plasma pro-
tein depletion. A relationship was found between plasma transfer-
rin concentration and ASP. ASP depletion seemed to be related to
the level of renal insufficiency. However, the most important factor
in ASP depletion was probably an inadequate protein intake asso-
ciated with the possible metabolic effects of uremic toxins which
are currently unknown.
Variations des proteines intracellulaires du muscle chez les enfants
en insuffisance renale severe. Les proteines alkali solubles (ASP) ont
été dosées dans Ic muscle de 17 enfants normaux et de 32 uré-
miques qui comprenaient 9 hémodialysés. Par rapport au contenu
en solides dégraisses, les valeurs de ASP sont plus basses chez les
urémiques que chez les normaux (59.2 + 1.6 g/l00 g FFS vs. 76.4
+ 1.9 g/lOO g FFS). Cette diminution est encore plus nette chez les
enfants hémodialyses (53.8 1.6 g 100 g FFS). La déplétion en
ASP est également manifeste quand les résultats sont exprimés par
rapport au potassium et au phosphore musculaires. Ainsi, dIe
apparaIt comme une réelle diminution de Ia quantité de protéines
par cellule. Les valeurs de ASP sont particulièrement basses (52.2
2.8 g/lOO g FFS) chez sept enfants non dialyses qui recevaient
un régime pauvre en protéines ( 0.165 g N/kg/jour) et chez les
malades dont Ia taille était inférieure a —2 D. 5. (56.3 + 3.1 g/100 g
FFS). Dans neuf cas de glomérulonephrite Ia perte des protéines
du muscle est parallèle a la déplétion protéique plasmatique. Nous
avons trouvé une correlation entre Ic taux de Ia transferrine et celui
des ASP. La déplétion en ASP est en relation avec Ic degré
d'insuffisance rénale. Cependant Ic principal facteur entralnant une
déplétion d'ASP semble être un apport inadequat en protéines; cc
facteur étant peut-être associé a des effets mCtaboliques des toxines
urémiques, effets actuellement inconnus.
Abnormalities in plasma protein and amino acid
concentration have been reported in many different
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studies of chronic renal failure in nondialyzed and
dialyzed patients. The most frequent findings include
1) a decrease in concentrations of serum albumin [I]
and plasma transferrin [2], 2) qualitative change in
plasma protein with a decrease in the binding proper-
ties of plasma albumin [3] and 3) a decrease in essen-
tial amino acid concentrations with a reduced va-
line/glycine ratio [4].
However, very little is known of the cell nitrogen
content in uremia. Low muscle protein content has
been found in uremic rats [5]. Some authors [6, 7]
have described a low alkali soluble protein content in
adults. More recently, the intracellular free amino
acids have been analyzed in the muscle of uremic
adults [81. Concentrations of some amino acids were
considerably higher than in plasma. Thus, there are
specific abnormalities of intracellular proteins in
uremia which may not be explained on the basis of
catabolism alone.
In children there is an extensive literature about the
cell constituents in protein calorie malnutrition. To
our knowledge no similar studies have been made in
children with chronic renal failure. Since they present
impaired growth and are often undernourished, cell
protein content in uremic children was especially in-
teresting to investigate. In this study we have com-
pared muscle protein content in normal and severely
uremic children. The relationship to primary disease,
hemodialysis, dietary protein intake and growth re-
tardation was determined. The results were also an-
alyzed in relation to the biological indexes of plasma
creatinine, plasma albumin, transferrin and muscle
electrolytes.
Patients and methods
Muscle biopsies were performed in 32 children
with chronic renal failure. Of these patients 23 had
severe renal failure with plasma creatinine values
equal to or greater than 5 mg/lOO ml. The remaining
nine had been undergoing hemodialysis eight hours
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twice weekly for six months or more with Rhone
Poulenc 5 or Gambro Minor dialyzers. Their primary
disease, clinical and laboratory data are recorded in
Table I. Of the 23 severely uremic children, 14 under-
went a dietary survey. Calculation of dietary nitrogen
and calorie intake were based on an analysis of the
actual food ingested during a three-day period each
month for at least six months. Seven consumed a low
protein diet with a nitrogen content equal to or less
than 0.165 g/kg of body wt daily (group I). The
remaining seven children received a diet with a nitro-
gen intake equal to or greater than 0.250 g/kg of
body wt/day (group II). Mean calorie intake was 53
Kcal/kg/day (65% RDA) in group I and 63
Kcal/kg/day (69% RDA) in group II. These two
groups were similar in statural age (mean, 10½ yr;
range, 7 to 14 yr).
The patients (mean age, 11 5/12 yr; range, 4 to 20
yr) were compared to 17 normal controls (mean age,
9 yr; range, 4 to 18 yr). In the control group one
subject was 18-yr-old. In the patient group, five were
older than 15 yr. However, their height and bone
maturation were retarded. Thus, these five subjects
were considered children. All children in the control
group were considered normal after clinical exam-
ination and the measurement of height, weight, tem-
perature and plasma electrolyte and blood urea nitro-
gen concentrations were found to be normal, In 12
controls admitted for orthopedic surgery, muscle tis-
sue from the quadriceps femoris was obtained at the
time of surgery. The five remaining controls had been
admitted for a benign and brief illness (pharyngitis).
Their muscle tissue was obtained during their con-
valescence by needle biopsy. All biopsies were per-
formed with informed parental consent.
In the uremic children the muscle tissue was ob-
tained by a needle biopsy in the middle of the quad-
riceps femoris muscle according to the technique of
Bergstrom [7]. The muscle specimen, weighing 20 to
30 mg, was cut into two pieces after removing blood,
connective tissue and fat, Both samples were dried
and the fat was extracted with petroleum ether (boil-
ing point, 40 to 60°). Electrolytes were then deter-
mined by the neutron activation analysis technique
[9]. After irradiation, one of the muscle specimens
was taken for the determination of alkali-soluble pro-
tein (ASP), The tissue was homogenized with an all
glass Potter-Elevhjen homogenizer after swelling for
24 hr at room temperature in I ml of 0.1M NaOH.
After centrifugation, the supernatant was collected.
The homogenate was resuspended and washed twice
in 0.4 ml of 0.IM NaOH. After further centrifugation
the supernatants were added to the first one and
the volume was adjusted exactly to 2 ml with 0.lM
NaOH.
The alkali-soluble protein analyses were made in
triplicate on 0.050 ml of supernatant according to
Lowry's technique with the Folin-phenol reagent
[10]. The results were expressed in grams per 100
grams of fat-free solids (FFS). In order to determine
the role of the drying and the irradiation on the
protein determination, we performed protein analy-
ses on two pieces of six specimens, one while wet, the
other, after having been dried and irradiated. The
results, as previously reported [11], did not show any
significant difference (Student's t test: P = 0.22).
Thus, the previous treatment of the muscle did not
alter the accuracy of electrolyte and protein determi-
nations on the same specimen.
Blood samples were collected at the same time as
the needle biopsy specimen for determination of the
concentrations of blood urea nitrogen, plasma creati-
nine, total proteins and electrolytes. The plasma al-
bumin concentration was determined in all but two
nondialyzed children. Plasma transferrin was meas-
ured in ten cases according to the Mancini technique
[12]. In order to establish a relationship between
plasma transferrin and the muscle protein content,
four additional children with moderate renal failure
underwent a muscle biopsy and plasma transferrin
determination. Their results were recorded with those
of the ten severely uremic patients.
Results
The ASP values are reported in Table I and Fig. 1.
Average values are accompanied by the SEM.
I. Compared to the normal controls, uremic chil-
dren exhibited a decrease in muscle protein content.
In 17 of the 23 severely uremic children, the muscle
protein (ASP) was lower than the lowest value meas-
ured in the normal children. The mean control value
for ASP was 76.4 1.9 g/lOOg of FFS as compared
to 59.2 + 1.6 g/ 100 g of FFS in uremic children (P <
0.001). The ASP decrease was also found when the
results were expressed in relation to total muscle po-
tassium (ASP/K ratio: uremic, 1.30 0.03; control,
1.78 + 0.06; P < 0.01) and to muscle phosphorus
(ASP/P ratio: uremic, 1.99 0.08; control, 2.68
0.09; P < 0.01).
In hemodialyzed children the mean value was sig-
nificantly lower than in the severely uremic patients
(53.8 1.6 g/lOO g of FFS). The dialyzed patient
group was too small and too heterogeneous to permit
accurate analysis of data. Nevertheless, it was noted
that no relationship existed between the ASP de-
crease and the duration of time since the beginning of
the dialysis.
11. The following results concern the group of non-
dialyzed children. In this group the protein concen-
tration did not vary with the primary disease. The
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mean value from patients with glomerulonephritis
was 57.7 2.4 vs. 60.6 + 2.1 g/lOOg of FFS in the 14
patients with nonglomerular disease. An inverse rela-
tionship was found between the plasma creatinine
concentration and muscle protein (r —0,49; P <
0.02). Creatinine production was not evaluated in our
study. No relationship was obtained between creati-
nine excretion and ASP since our patients had ac-
tually poor residual renal function. There was a sig-
nificant decrease of muscle protein in seven children
on a low protein diet (group I) when compared with
the seven others (group II) (52.2 2.8 vs. 66.3 + 2.0
g/100 g of FFS, P < 0.01) (Fig. I). When protein
intake was expressed as a percentage of the recom-
mended dietary allowance (RDA, 1968) [13], the dif-
ference between the two groups (65%, group 1; 77%,
group II) persisted but was not significant.
We found that children with a high diastolic blood
pressure (> 80 mm Hg) had lower muscle protein
values than those with normal diastolic blood pres-
sure (56.4 + 2.0 vs. 66.2 2.5 g/l00 g of FFS, P <
0.01). However, among the children with hyperten-
sion, six belonged to the group of patients who were
receiving a low protein diet.
A positive correlation between the plasma transfer-
nfl concentration and the ASP's was demonstrated in
14 determinations from patients with both non-
glomerular and glomerular diseases (r = 0.64, P <
0.01) (Fig. 2).
III. Some correlations were evident only when the
glomerular diseases were considered separately. The
patients with nonglomerular disease were divided ac-
cording to severity of growth retardation. A signifi-
cantly lower protein content was found in the muscle
of children with a height inferior to 2 SD below the
mean for age as compared to those with a height
equal to or greater than 2 SD below the mean for age
(56.3 3.1 vs. 64 1.8 g/lOO g of FFS, P< 0.01)
(Fig. 3).
In the nine cases of glomerulonephritis, direct and
significant correlations were found between the total
plasma protein concentration and the muscle protein
(r = 0.80, P < 0.01) and between the plasma albumin
and the muscle protein (r = 0.79, P< 0.01) (Fig. 4).
Discussion
Before discussing the data, it is necessary to assess
the reliability of our results: the reason for using
ASP's as a measure of cell protein rests on the obser-
vation that cell proteins dissolve completely in di-
luted alkali whereas collagen and elastin are insoluble
[14]. Several groups have determined noncollagen
nitrogen or noncollagen protein in muscle of adult
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Fig. I. ASP values in normal and uremic children. Values are in relation to FFS, muscle
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man [15—17]. Our normal values in children are sim-
ilar to the values obtained in adults when expressed
as grams of protein per unit of FFS. In the uremic
children, low values of ASP were observed using
three different bases of reference: FFS, potassium
and phosphorus. None of these references is satisfac-
tory for the assessment of intracellular protein deple-
tion, i.e., evaluation of the protein content per "unit
cell". A better reference would have been the DNA
content of the tissue; however, no reliable method of
detemination was available to us at the time of in-
vestigation. The decreased content of ASP in relation
to FFS simply reflects the fact that the proportion
between cell protein and other solids, presumably
connective tissue like collagen and elastin, is changed.
It is not sufficient to indicate either a decrease in the
absolute amount of cell protein or an increase in the
amount of connective tissue. It is conceivable that
both events occur simultaneously, i.e., the muscle
proteins decrease and a reduction occurs in the num-
ber of cells as they are gradually replaced by con-
nective tissue.
The fact that ASP is also decreased in relation to
potassium and phosphorus provides further evidence
that the amount of protein per cell is decreased. Al-
though muscle potassium and phosphorus are ele-
vated in uremia, they do not accumulate enough in
the cells to explain the decrease of ASP/K and
.
2sD >2so
Growth retardation
Fig. 3. Repartition of the ASP value according to the growth retarda-
tion in 14 patients with nonglomerular diseases.
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Fig. 4. Relationship of ASP to plasma protein concentration (r =
0.80, P < 0.01) and ASP to plasma albumin concentration (r = 0.79,
P < 0.01) in the patients with glomerulonephritis.
ASP/P ratios. The decrease of these ratios implies an
actual protein deficit regarding the total electrolyte
content since these ratios remain low when calculated
with normal values of muscle potassium and phos-
phorus. When the results are extrapolated to the wet
tissue, the relative concentration of proteins to in-
tracellular water and ions is reduced. Earlier studies
in chronic uremia have shown that intracellular po-
tassium concentration is not significantly different
from normal in spite of the potassium content per 100
g of FFS being high [181. In the present material the
intracellular potassium concentration was also within
the normal range (unpublished observation). This
implies that the ratio of intracellular water to FFS
was also proportionaly increased, an effect which
may occur if the solid content per cell is low. In
conclusion, the results suggest that there was a loss of
muscle cell mass and also a low concentration of
intracellular protein in the remaining cell.
.
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Several factors may have contributed to the ASP
depletion. Anorexia, nausea, vomiting and low so-
dium diet are commonly encountered in severe
uremia and may contribute to an inadequate intake
of protein and calories. High blood pressure may
enhance some of these phenomena and this may ex-
plain the lower ASP value found in hypertensive
patients. A diminution in physical activity may lead
to an involution in muscle mass. In ten immobilized
orthopedic surgical patients, we noted a decrease in
the ASP concentration in tissue taken from an oper-
ative site. This was, however, probably due to an
increase in connective scar tissue. Although the
uremic patients appeared to be less active than nor-
mal, none were immobilized; their physical activity
was not systematically examined.
The prescription of a protein-restricted diet seems
to be deleterious to the patient since such a diet
appeared to cause a more severe muscle protein de-
pletion than a more liberal protein regimen. How-
ever, some patients with a subnormal protein intake
(approximately 1 g/kg of body wt/day) had an ob-
vious muscle protein depletion. This raises the ques-
tion of the protein requirements in uremic children,
which has not been thoroughly investigated. It has
been shown in adult patients treated with intermittent
dialysis that a protein intake of I g/kg of body
wt/day appeared to be inadequate to prevent signs of
depletion in plasma proteins and essential amino
acids [19, 20]. However, this level of protein intake is
considered to be more than adequate to maintain
nitrogen balance in normal subjects. These results
suggest that uremic patients have an increased re-
quirement for protein.
It is not sufficient to consider only the quantity of
proteins but also their biological value. Nitrogen bal-
ance has, however, been achieved in uremic adults
with much lower protein intake (0.3 to 0.4 g/kg of
body wt/day) when the diet was supplemented with
two to three times the normal requirement of essen-
tial amino acids including histidine (EAA + HIS)
[21]. A return to normal concentrations of plasma
proteins was observed in hemodialyzed adults with a
protein intake of I g/kg of body wt/day when EAA
+ HIS were added to the diet [20]. An improvement
of growth has been obtained in nephrectomized rats
using a low protein diet supplemented with small
amounts of EAA + HIS [22]. These results suggest
that the essential amino acid requirement is increased
in severe renal failure. Our data do not allow a defi-
nite conclusion on this point.
Since protein depletion is a factor which retards
growth, a more adequate protein diet with a supple-
ment of essential amino acids should be tried. Never-
theless, an improvement in nutritionnal status can be
expected only if a sufficient calorie intake is provided
at the same time as has been demonstrated in uremic
children [23—25]. Calories have a sparing effect on
proteins. Moreover, a positive nitrogen balance can-
not be achieved in calorie undernutrition, The rela-
tionship between ASP and protein intake could vary
similarly with calorie intake. In fact, if this relation-
ship does not appear significant in the present study,
it is probably attributable to the narrow range of the
data.
In evaluating the data, protein loss must be consid-
ered to be a factor in determining ASP values. Four
of nine patients with glomerulonephritis had a low
plasma protein concentration secondary to the neph-
rotic syndrome. The correlation between low ASP
values and plasma proteins in this group of patients
must be examined in cognizance of this fact; that is,
the low ASP values in patients with glomeruloneph-
ntis may be partially attributable to a significant loss
of protein in the urine.
In patients treated with hemodialysis, loss of
amino acids during dialysis may be an additionnal
factor. Several investigators [26—28] have demon-
strated removal of free and bound amino acids by
dialysis. According to a previous study [29], this loss
could come primarily from the intracellular pool.
However, we found that the highest ASP concentra-
tions in the dialyzed patients were in two children
who had been undergoing hemodialysis for more
than two years. Thus, it is unlikely that amino acid
loss during dialysis is a major factor in lowering ASP.
Uremic toxicity may also be a factor contributing
to ASP depletion. The metabolic disturbances may
decrease protein synthesis or increase protein catabo-
lism or both and could affect the protein requirement
in the uremic state. No conclusive data regarding the
role of uremic toxins on protein metabolism are
available, Nevertheless, the relationship between
ASP values and plasma creatinine concentration al-
lows the postulate that the substances accumulating
in uremia could have some effect on the muscle pro-
tein metabolism.
Analysis of our data suggests some other impor-
tant relationship between ASP values and the uremic
syndrome.
A correlation between low ASP values in children
with nonglomerular disease and short stature was
clearly defined. This group of patients was composed
of those with congenital renal disease. Hence, the
duration of illness may have been an additional
factor contributing to prolonged insufficient food
intake and subsequent growth retardation.
We have shown a highly significant correlation
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between plasma transferrin concentration and muscle
protein content. These indexes appeared to be inde-
pendent of the primary disease but varied with the
degree of renal insufficiency. Some investigators [30,
31] have demonstrated low plasma transferrin con-
centrations in patients with chronic uremia and con-
sidered this to be a sign of protein malnutrition. Our
findings further demonstrate that transferrin is a
valuable index of protein deficiency since it reflects
the cell protein content in the muscle compartment.
This study suggests that the ASP depletion in the
muscle of uremic children results chiefly from an
inadequate nitrogen intake. The influence of the
metabolic disorders attributable to uremic toxins re-
mains to be investigated.
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